Insys Executives' Racketeering Trial Jury Starts Deliberations
John N. Kapoor departs the John Joseph Moakley United States Courthouse in Boston on Jan. 29, 2019.
Photographer: Craig F. Walker/The Boston Globe via Getty Images
This article is for subscribers only.
A Boston federal jury has started deliberations in the racketeering trial of Insys Therapeutics Inc. founder John Kapoor and four other former executives over the promotion of the opioid painkiller Subsys.
Federal prosecutors called 39 witnesses in the trial that spanned two months. The defense took two days and featured a handful of witnesses, including a patient who vouched for the benefits of Subsys. Neither Kapoor nor the other defendants testified.